PSyGenTAB: A Privacy-Preserving Framework for Synthetic Clinical Tabular Data Generation via Constrained Optimization

The Privacy-Utility Frontier in Medical AI

A new preprint from arXiv (2606.18518v1) introduces PSyGenTAB, a framework designed to generate synthetic clinical tabular data while preserving patient privacy through constrained optimization. The research addresses a fundamental bottleneck in medical AI: the tension between data utility and regulatory compliance under HIPAA and GDPR.

What Happened

PSyGenTAB tackles the synthetic data generation problem by framing it as a constrained optimization task rather than relying solely on generative models like GANs or VAEs. The approach explicitly enforces privacy guarantees—likely differential privacy or similar formal protections—while optimizing for statistical fidelity to the original clinical dataset. This differs from typical synthetic data methods that either sacrifice utility for privacy or vice versa.

The framework specifically targets tabular clinical data, which remains the dominant format in healthcare records (lab results, vital signs, medication histories), as opposed to imaging or text data that receives more attention in medical AI research.

Why It Matters

The healthcare industry sits on vast quantities of underutilized data. Institutional silos and privacy regulations mean that even within a single hospital system, data sharing across departments can be legally fraught. For multi-institutional research—crucial for rare diseases or diverse patient populations—the barriers multiply.

Current synthetic data approaches often fail in practice because:

• GAN-generated tabular data frequently produces unrealistic correlations between variables
• Simple noise injection destroys the statistical patterns needed for model training
• Rule-based generation cannot capture complex clinical dependencies

PSyGenTAB’s constrained optimization approach offers a middle path: mathematically guaranteed privacy bounds while preserving the joint distributions that make clinical data useful for downstream tasks like risk prediction or treatment effect estimation.

Implications for AI Practitioners

For data scientists working in regulated healthcare environments, this framework could reduce friction in several ways:

• Accelerated model development: Synthetic datasets that pass privacy audits could be shared freely across teams, eliminating the need for each group to navigate separate data access agreements.

• Reproducible research: Currently, clinical ML papers often cannot release their training data. A high-fidelity synthetic alternative would allow independent verification of results without exposing patient information.

• Federated learning alternative: While federated learning keeps data in place, it introduces communication overhead and model synchronization challenges. High-quality synthetic data could enable centralized training without the infrastructure costs.

The key question remains whether PSyGenTAB’s constrained optimization scales to large clinical datasets with thousands of variables and whether the privacy-utility tradeoff is favorable enough for production use. The preprint’s experimental results will be critical for assessing real-world viability.

Key Takeaways

• PSyGenTAB proposes a constrained optimization approach to synthetic clinical data generation, explicitly balancing privacy guarantees against data utility
• The framework targets tabular clinical data—the most common but often overlooked format in medical AI research
• If validated, this could reduce legal and operational barriers to data sharing in healthcare, accelerating model development and enabling reproducible research
• Practitioners should watch for published benchmarks comparing PSyGenTAB’s privacy-utility tradeoff against existing GAN and VA-based methods on real clinical datasets